CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
ABOPEN is a user-friendly, off-the-lab test that identifies the RhD factor type in pregnant women, aiming to prevent Hemolytic Disease of the Fetus and Newborn. It is affordable, requires no electricity, and can be used by non-trained personnel, making it suitable for developing regions.
Despite being eradicated from the developed world, the Rhesus Disease or HDFN (Hemolytic Disease of the Fetus and Newborn), a disease where the immune system from the mother attacks the red blood cells from their babies, still kills 141,000 children and mothers in developing regions every year.
Deaths that could be easily prevented by screening pregnant women for their RhD factor type.
Although 15% of RhD(-) women are at risk, 220 million women in developing countries should be tested, since the…
ELDON BIOLOGICALS A/S
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
